SANTA MONICA, Calif., March 28, 2018 -- UBM and the Massachusetts Medical Device Industry Council (MassMEDIC) will partner for the fourth annual Massachusetts Medtech week, bringing together two of the region’s most respected medical technology authorities to provide top educational content featuring the latest innovations in medical technology at BIOMEDevice Boston 2018 and MassMEDIC’s 22nd Annual Conference. The events will also host Jeff Karp, Professor of Medicine at Brigham and Women’s Hospital, Harvard Medical School and MIT as the 2018 keynote speaker, providing insight into biomedical innovation and regenerative medicine.
BIOMEDevice Boston 2018 and MassMEDIC’s 22nd Annual Conference will take place in conjunction on April 18-19, 2018 at the Boston Convention and Exhibition Center. To apply for a media pass, please visit: boston.am.ubm.com/2018/registrations/Media
“Our partnership with MassMEDIC has been tremendously successful over the past four years and is a direct testament to the thriving medical technology industry that is ubiquitous in New England,” said Nina Brown, vice president of events, UBM. “We are pleased to play a large role in Massachusetts Medtech week by hosting the most important technologies and trends that will enhance this evolving industry in the coming years.”
In addition to providing unprecedented educational content and a plethora of networking opportunities, the two events will host more than 4,500 industry engineers and executives and will house 450 leading suppliers across the region’s thriving medical technology industry.
“We’re excited to again bring two well-respected industry events together to headline Massachusetts Medtech Week, one of the most important weeks of the year for New England’s medical technology industry. The partnership between MassMEDIC and UBM benefits both the local industries and the region as a whole,” said Tom Sommer, president, MassMEDIC. “We are also thrilled to welcome Jeff Karp, Professor of Medicine at Brigham and Women’s Hospital, Harvard Medical School and MIT, to our event. Jeff is at the forefront of regenerative medicine and will share invaluable insights on the topic in his keynote presentation.”
About Jeff Karp:
Dr. Jeff Karp is an Associate Professor of Medicine at Brigham and Women's Hospital, Harvard Medical School, Principal Faculty at the Harvard Stem Cell Institute, and an affiliate faculty at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology. His work spans the fields of drug delivery, medical devices, stem cell therapeutics and tissue adhesives. In addition to his research, Karp is dedicated to the career development of next-generation bioengineers working at the forefront of regenerative medicine. Karp strives to create an educationally conducive environment that fosters the development of scientific confidence.
In his keynote presentation, Biomedical Innovation- A Report from the Frontier, Karp will share insights from his long and successful career in regenerative medicine, and also explore the latest in biology and medicine. Karp’s keynote presentation will take place Wednesday, April 18 from 12:00- 12:30 PM.
Embedded Systems Conference (ESC) Boston and Design and Manufacturing New England will also run alongside BIOMEDevice Boston and MassMEDIC’s 22nd Annual Conference.
Register as press for BIOMEDevice Boston: boston.am.ubm.com/2018/registrations/Media.
Connect with BIOMEDevice Boston: #AdvMfgExpo
Media Contacts:
UBM: Rich Trunzo, [email protected], (424) 316-7169
MassMEDIC: Larry Carpman, [email protected], (617) 905-6633
About UBM Advanced Manufacturing Expos & Conferences
UBM's Advanced Manufacturing portfolio is the leading B-to-B event producer, publisher, and digital media business for the world's $3 trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the advanced manufacturing market and leverage our proprietary 1.3 million name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Advanced Manufacturing portfolio is organized by UBM plc. UBM is the largest pure-play B2B Events organizer in the world. Our 3,750+ people, based in more than 20 countries, serve more than 50 different sectors. Our deep knowledge and passion for these sectors allow us to create valuable experiences which enable our customers to succeed. Please visit www.ubm.com for the latest news and information about UBM.
About MassMEDIC
MassMEDIC, an organization of more than 300 manufacturers, suppliers, research institutions, and academic health centers, promotes the unique interests of the Bay State’s growing and vibrant medical device sector. Through a variety of programs, informational seminars, advocacy campaigns and other projects, MassMEDIC provides the medical device sector with key information on industry trends and regulatory policies, and creates forums that allow members to exchange ideas and information on issues affecting the industry. Visit www.massmedic.com.


UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Apple Restores Telegram to App Store After Content Policy Violation
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Telegram Restored on Apple App Store After Temporary Removal
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 



